Ami Fadia

Stock Analyst at Needham

(1.7)
# 1621
Out of 5,441 analysts
508
Total ratings
Success rate
Average return
39 Stocks
Name Action PT Current % Upside Ratings Updated
RVMD Revolution Medicines
Maintains: Buy
57 56
34.71 61.34% 25 Aug 7, 2025
MRUS Merus
Maintains: Buy
97 96
64.6 48.61% 30 Aug 6, 2025
DAWN Day One Biopharmaceu...
Maintains: Buy
18 16
5.91 170.73% 21 Aug 6, 2025
AXSM Axsome Therapeutics
Reiterates: Buy
150 150
103.95 44.3% 16 Aug 4, 2025
ALKS Alkermes
Reiterates: Buy
45 45
26.55 69.49% 3 Jul 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
30 30
24.83 20.82% 10 Jun 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
9 9
3.23 178.64% 17 Jun 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 23 Jun 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 22 Jun 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
80 80
44.96 77.94% 12 Jun 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 41 Jun 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
202 202
110.76 82.38% 32 Jun 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
130 130
129.46 0.42% 31 Jun 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
16.6 110.84% 1 May 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
1.44 247.22% 9 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
19 19
12.79 48.55% 36 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
49 49
34.83 40.68% 37 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
138 139
123.99 12.11% 14 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
29 29
7.46 288.74% 20 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 27 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 6 Jul 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 7 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
n/a
n/a n/a 1 Dec 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
40
14.7 172.11% 1 Feb 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
28 26
26.98 -3.63% 6 Feb 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
240 320
14.88 2050.54% 2 Feb 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
63 75
25.19 197.74% 7 Jan 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
4 5
n/a n/a 2 Jan 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
10 14
n/a n/a 3 Oct 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
15 23
0.72 3025% 4 Oct 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
64 63
22.01 186.23% 4 Sep 17, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
2 2
n/a n/a 8 Sep 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
8 10
1.11 800.9% 2 Jul 10, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
24
n/a n/a 8 Jan 27, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
9 20
n/a n/a 2 Sep 17, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
12 5
4.66 7.3% 2 Jan 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Market Perform
n/a
n/a n/a 7 Oct 1, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
12
n/a n/a 5 Jan 3, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
22
1.27 1632.28% 4 Jan 3, 2018